SPEAKERS

Myomatrix in Health and Disease:

Peter Yurchenco - USA - Mechanism of laminin assembly: Insight for structural repairs of MDC1A
Elizabeth McNally - USA - Myomatrix modification in muscular dystrophy
Markus Ruegg - Switzerland - The role of laminins in myomatrix assembly and skeletal muscle stability
Paul Martin - USA - Progress in gene therapy for muscular dystrophy using vascular delivery of GALGT2

Immunity and Muscle Disease:

Olivier Benveniste - France - Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis:
                                                          Which came first the chicken or the egg?
Alan Pestronk - USA - Acquired immune and inflammatory myopathies: Pathologic description and classification
Diane Shelton - USA - Large animal models of inflammatory myopathies and myasthenia gravis
Jan de Bleecker - Belgium - Role of cytokines and chemokines in inflammatory myopathies

Advances in Therapy for Neuromuscular Diseases

Gillian Butler-Browne - France - Cell therapy in muscular dystrophies
George Dickson - United Kingdom - Microdystrophin gene therapy: Design, delivery and function
Silvere van de Maarel - Netherlands - The converging disease mechanisms in FSHD1 and FSHD2
Alessandra Ferlini - Italy - How to evaluate upcoming therapies: The role of biomarkers
Charles Thornton - USA - Targeted therapies for myotonic dystrophy